Tekla Capital Management LLC Thermo Fisher Scientific Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 98,987 shares of TMO stock, worth $54.5 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares

98,987

Previous 93,705 5.64%

Holding current value

$54.5 Million

Previous $54 Million 4.37%

% of portfolio

2.04%

Previous 2.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$508.46 - $591.13 $2.69 Million - $3.12 Million	5,282 Added 5.64%	98,987 $51.6 Million
Q3 2022 Nov 01, 2022	SELL	$507.19 - $604.49 $1.98 Million - $2.36 Million	-3,900 Reduced 4.0%	93,705 $47.5 Million
Q1 2022 May 13, 2022	SELL	$524.0 - $644.92 $28.7 Million - $35.3 Million	-54,721 Reduced 35.92%	97,605 $57.7 Million
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $3.53 Million - $4.14 Million	6,210 Added 4.25%	152,326 $102 Million
Q3 2021 Nov 12, 2021	BUY	$509.53 - $609.78 $3.05 Million - $3.65 Million	5,986 Added 4.27%	146,116 $83.5 Million

Q2 2021 Aug 13, 2021	BUY	$441.0 - $508.24 $11.7 Million - $13.5 Million	26,477 Added 23.3%	140,130 $70.7 Million
Q1 2021 May 14, 2021	SELL	$439.85 - $518.83 $6.11 Million - $7.21 Million	-13,900 Reduced 10.9%	113,653 $51.9 Million
Q4 2020 Feb 12, 2021	BUY	$435.06 - $527.66 $42.7 Million - $51.8 Million	98,092 Added 332.96%	127,553 $59.4 Million
Q3 2020 Nov 13, 2020	SELL	$359.77 - $441.52 $27.5 Million - $33.8 Million	-76,564 Reduced 72.21%	29,461 $13 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $1.65 Million - $2.17 Million	-6,000 Reduced 5.36%	106,025 $38.4 Million
Q1 2020 May 14, 2020	SELL	$255.3 - $340.05 $2.91 Million - $3.87 Million	-11,383 Reduced 9.22%	112,025 $31.8 Million
Q4 2019 Feb 13, 2020	BUY	$271.93 - $328.04 $9.27 Million - $11.2 Million	34,098 Added 38.18%	123,408 $40.1 Million
Q3 2019 Nov 13, 2019	SELL	$268.46 - $305.43 $12.6 Million - $14.3 Million	-46,888 Reduced 34.43%	89,310 $26 Million
Q2 2019 Aug 14, 2019	SELL	$257.51 - $295.55 $1.69 Million - $1.93 Million	-6,545 Reduced 4.59%	136,198 $40 Million
Q1 2019 May 14, 2019	SELL	$212.17 - $273.72 $10.4 Million - $13.5 Million	-49,152 Reduced 25.61%	142,743 $39.1 Million
Q4 2018 Feb 13, 2019	BUY	$208.47 - $251.98 $2.4 Million - $2.9 Million	11,500 Added 6.37%	191,895 $42.9 Million
Q3 2018 Nov 13, 2018	BUY	$205.57 - $244.32 $5.69 Million - $6.77 Million	27,700 Added 18.14%	180,395 $44 Million
Q2 2018 Aug 13, 2018	BUY	$203.14 - $219.53 $983,197 - $1.06 Million	4,840 Added 3.27%	152,695 $31.6 Million
Q1 2018 May 14, 2018	BUY	$192.98 - $224.11 $1.91 Million - $2.22 Million	9,887 Added 7.17%	147,855 $30.5 Million
Q4 2017 Feb 14, 2018	SELL	$182.03 - $200.37 $14.8 Million - $16.3 Million	-81,104 Reduced 37.02%	137,968 $26.2 Million
Q3 2017 Nov 13, 2017	BUY	$171.74 - $194.04 $13.7 Million - $15.5 Million	79,952 Added 57.47%	219,072 $41.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	139,120	139,120 $24.3 Million

Others Institutions Holding TMO

# of Institutions

2,722

Shares Held

331M

Call Options Held

1.58M

Put Options Held

2.01M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $216B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Thermo Fisher Scientific Inc. Transaction History